CATHERINE C. TURKEL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CATHERINE C. TURKEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CATHERINE C. TURKEL. CATHERINE C. TURKEL is Chief Development Officer in Novus Therapeutics, Inc. ($TKAI) and President in Novus Therapeutics, Inc. ($TKAI).
Latest Insider Trading Transactions of CATHERINE C. TURKEL
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2020 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 0.26 | 100,000 | 26,000 | 100,000 | |
| Sep 30 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
| Sep 30 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
| May 22 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Sell | S | 1.91 | 1,914 | 3,658 | 88,662 | 90.6 K to 88.7 K (-2.11 %) |
| May 22 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Sell | S | 1.96 | 7,623 | 14,953 | 90,576 | 98.2 K to 90.6 K (-7.76 %) |
| Mar 18 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 3.72 | 50,000 | 186,000 | 50,000 | |
| Mar 18 2019 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Grant | A | 0.00 | 20,000 | 0 | 98,199 | 78.2 K to 98.2 K (+25.58 %) |
| Sep 13 2018 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Buy | P | 5.02 | 16,632 | 83,476 | 78,199 | 61.6 K to 78.2 K (+27.01 %) |
| Sep 13 2018 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Buy | P | 4.56 | 17,048 | 77,671 | 61,567 | 44.5 K to 61.6 K (+38.29 %) |
| Sep 07 2018 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Buy | P | 3.97 | 805 | 3,193 | 805 | 0 to 805 |
| Sep 07 2018 | NVUS | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Buy | P | 3.97 | 805 | 3,193 | 805 | 0 to 805 |
| Mar 15 2018 | TKAI | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 4.83 | 24,000 | 115,920 | 24,000 | |
| Mar 15 2018 | TKAI | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Grant | A | 0.00 | 20,000 | 0 | 44,519 | 24.5 K to 44.5 K (+81.57 %) |
| Nov 06 2017 | TKAI | Novus Therapeutics ... | TURKEL CATHERINE C. | President | Option Exercise | A | 4.21 | 50,000 | 210,500 | 50,000 | |
| May 26 2017 | TKAI | Novus Therapeutics ... | TURKEL CATHERINE C. | Chief Development O ... | Option Exercise | A | 5.50 | 52,500 | 288,750 | 52,500 | |
| May 11 2017 | TKAI | Novus Therapeutics ... | TURKEL CATHERINE C. | Chief Development O ... | Buy | P | 9.99 | 11,111 | 110,999 | 24,519 | 13.4 K to 24.5 K (+82.87 %) |
Page: 1